QUB spin-out Aramune raises £800,000 to scale its health product

1 month ago 91

Belfast-based Aramune Technologies has raised £800,000 in seed equity funding to scale the production of its patented plant-based health products.

A Queen’s University Belfast spin-out, Aramune is developing natural, plant-derived feed materials which can be mixed with standard animal feeds to replace antimicrobial agents and promote growth – benefitting animal and human health.

The product aims to boost the immune system of the host organism instead of the infectious one, increasing natural resistance to bacterial infection and minimising the occurrence of antimicrobial resistance (AMR) in animals and humans.

“We are delighted to have secured this funding from local investors who are committed to supporting Queen’s spin-out ventures and the local economy,” said Aramune CEO Ashley Cooper.

“With this funding we are now well placed to rapidly exploit the very many commercial applications of our proprietary Aramune compound.”

The investment was led by QUBIS, the commercialisation arm of Queen’s University, Co-Fund NI managed by Clarendon Fund Managers, the QUBIS Innovation Fund managed by Sapphire Capital Partners, as well as a local private investor.

Proceeds from the investment are expected to enable Aramune to field cultivate their source plants, industrially scale their compound extraction procedures and undertake more commercial trials.

Last year, the start-up won £300,000 in funding from Innovate UK and were regional winners of the InterTradeIreland Seedcorn Investor Readiness competition.

“This investment is a vote of confidence in the commercial potential of our research, and it follows on from Aramune’s recent successes,” said Brian Green, chief scientific officer of Aramune.

“We are delighted to be able to invest into Aramune Technologies and back its experienced management team as part of this seed investment round,” added Stuart Gaffikin, an investment manager from Clarendon Fund Managers.

“We look forward to playing our role in supporting the company as it develops and commercialises its natural, plant-based products for use in animal health and nutraceuticals.”

10 things you need to know direct to your inbox every weekday. Sign up for the Daily Brief, Silicon Republic’s digest of essential sci-tech news.

The post QUB spin-out Aramune raises £800,000 to scale its health product appeared first on Silicon Republic.

Read Entire Article